MedPage Today October 21, 2022
Cheryl Clark

— “Secret shoppers” found that 80% of agent calls with clients were inaccurate or insufficient

After reviewing thousands of complaints about “confusing, misleading, and/or inaccurate” Medicare Advantage ads, and using “secret shoppers” to document deceptive telephone sales pitches, the Centers for Medicare & Medicaid Services (CMS) announced it is putting its foot down on Thursday.

Kathryn A. Coleman, director of the agency’s Medicare Drug and Health Plan Contract Administration Group, said in a three-page letter that CMS is immediately enhancing its review of marketing materials, which must be submitted under its regulatory “File and Use” authority for Medicare Advantage and Part D drug plans, and “may exercise its authority to prohibit” their use.

Currently, Medicare Advantage marketing materials may go...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
HHS: Ozempic, Wegovy will be part of Medicare Part D drug price negotiations this year
CMS says record 24.2 million enrolled in Marketplace coverage for 2025

Share This Article